nach oben

Erschienen in:

19.10.2018 | Original Article

Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma

verfasst von: Marco Raffaelli, Carmela De Crea, Luca Sessa, Serena Elisa Tempera, Amanda Belluzzi, Celestino P. Lombardi, Rocco Bellantone

Erschienen in: Endocrine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to evaluate risk factors for local recurrence following lateral neck dissection (LND) for papillary thyroid carcinoma (PTC).

Methods

Two hundred and nine patients who underwent therapeutic primary or reoperative LND for PTC were included.

Results

One hundred eighty-one patients underwent primary LND at our Institution, the remaining 28 were referred for recurrence following LND outside the Institution. Comparing patients who required reoperation for recurrent lateral neck disease with those who did not recur, no significant difference was found concerning sex, tumor size, multifocal disease, extracapsular invasion, histological variant, pT stage (P = NS). At univariate analysis, age, mean number of removed lateral neck nodes at first operation, the extent of initial LND and surgery performed outside the Institution were risk factors for recurrence (P < 0.001).

Conclusions

Limited LND and surgery performed at non referral Centers were non tumor-related risk factors for recurrence following therapeutic LND for PTC.

A.R. Shaha, J.P. Shah, T.R. Loree, Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am. J. Surg. 172(6), 692–694 (1996)CrossRefPubMed

J.L. Roh, J.Y. Park, C.I. Park, Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann. Surg. 245(4), 604–610 (2007)CrossRefPubMedPubMedCentral

L.Y. Wang, F.L. Palmer, I.J. Nixon et al., Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol. 22(11), 3530–3536 (2015)CrossRefPubMedPubMedCentral

C.W. Lee, J.L. Roh, G. Gong et al., Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. Surg. Oncol. 22, 117–124 (2015)CrossRefPubMed

Y.M. Lee, T.Y. Sung, W.B. Kim, K.W. Chung, J.H. Yoon, S.J. Hong, Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection. Br. J. Surg. 103(8), 1020–1025 (2016)CrossRefPubMed

V. Zaydfudim, I.D. Feurer, M.R. Griffin, J.E. Phay, The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144(6), 1070–1077 (2008). discussion 1077-1078CrossRefPubMed

D.F. Schneider, H. Chen, R.S. Sippel, Impact of lymph node ratio on survival in papillary thyroid cancer. Ann. Surg. Oncol. 20(6), 1906–1911 (2013)CrossRefPubMed

K. Segal, R. Friedental, E. Lubin, J. Shvero, J. Sulkes, R. Feinmesser, Papillary carcinoma of the thyroid. Otolaryngol. Head. Neck. Surg. 113, 356–363 (1995)CrossRefPubMed

Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J. Surg. 36, 593–597 (2012)CrossRefPubMed

10.

C.P. Lombardi, M. Raffaelli, C. De Crea, L. Sessa, R. Bellantone, Morbidity of central neck dissection: primary surgery vs reoperation. Results a case-control study. Arch. Surg. 399, 747–753 (2014)CrossRef

11.

Y. Ito, T. Higashiyama, Y. Takamura et al., Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral neck node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31(11), 2085–2091 (2007)CrossRefPubMed

12.

M. Javid, E. Graham, J. Malinowski et al., Dissection of levels II through V is required for optimal outcomes in patients with lateral neck lymph node metastasis from papillary thyroid carcinoma. J. Am. Coll. Surg. 222(6), 1066–1073 (2016)CrossRefPubMed

13.

B.R. Haugen, E.K. Alexander, K.C. Bible et al., 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedPubMedCentral

14.

F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2016)CrossRef

15.

P. Perros, K. Boelaert, S. Colley et al., British Thyroid Association. Guidelines for the management of thyroid cancer. Clin. Endocrinol. 81(Suppl 1), 1–122 (2014)CrossRef

16.

B.C. Stack, R.L. Ferris, D. Goldenberg et al., American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22, 501–508 (2012)CrossRefPubMed

17.

C.P. Hasney, R.G. Amedee, What is the appropriate extent of lateral neck dissection in the treatment of metastatic well-differentiated thyroid carcinoma? Laryngoscope 120(9), 1716–1717 (2010)CrossRefPubMed

18.

N.R. Caron, Y.Y. Tan, J.B. Ogilvie et al., Selective Modified Radical Neck Dissection for Papillary Thyroid Cancer—Is Level I, II and V Dissection Always Necessary? World J. Surg. 30, 833–840 (2006)CrossRefPubMed

19.

M.L. Urken, M. Milas, G.W. Randolph et al., Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative. Head. Neck 37(4), 605–614 (2015)CrossRefPubMed

20.

A. Machens, R. Hinze, O. Thomusch, H. Dralle, Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer. World J. Surg. 26, 22–28 (2002)CrossRefPubMed

21.

D.M. Hartl, S. Leboulleux, A.A. Ghuzlan et al., Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann. Surg. 255, 777–783 (2012)CrossRefPubMed

22.

A. Ohshima, H. Yamashita, S. Noguchi et al., Is a bilateral modified radical neck dissection beneficial for patients with papillary thyroid cancer? Surg. Today 32, 1027–1030 (2002)CrossRefPubMed

23.

S. Uchino, S. Noguchi, H. Yamashita, S. Watanabe, Modified radical neck dissection for differentiated thyroid cancer: operative technique. World J. Surg. 28, 1199–1203 (2004)CrossRefPubMed

24.

J.R. Porterfield, D.A. Factor, C.S. Grant, Operative technique for modified radical neck dissection in papillary thyroid carcinoma. Arch. Surg. 144(6), 567–574 (2009)CrossRefPubMed

25.

T. Farrag, F. Lin, N. Brownlee, Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J. Surg. 33, 1680–1683 (2009)CrossRefPubMed

26.

M. Merdad, A. Eskander, T. Kroeker, J.L. Freeman, Predictors of level II and Vb neck disease in metastatic papillary thyroid cancer. Arch. Otolaryngol. Head. Neck Surg. 138(11), 1030–1033 (2012)CrossRefPubMed

27.

K. Welch, C.R. McHenry, Selective lateral compartment neck dissection for thyroid cancer. J. Surg. Res. 184(1), 193–199 (2013)CrossRefPubMed

28.

D.T. Hughes, A.M. Laird, B.S. Miller, P.G. Gauger, G.M. Doherty, Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann. Surg. Oncol. 19, 2951–2957 (2012)CrossRefPubMed

29.

M. Salvatori, M. Raffaelli, P. Castaldi et al., Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Eur. J. Surg. Oncol. 33, 648–654 (2007)CrossRefPubMed

30.

American Joint Committee on Cancer. Thyroid. AJCC Cancer Staging Manual. 7th edn., Springer, New York. pp. 87−92 (2010)

31.

M. Raffaelli, C. De Crea, L. Sessa, G. Fadda, C. Bellantone, C.P. Lombardi, Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann. Surg. Oncol. 22, 2302–2308 (2015)CrossRefPubMed

32.

C.P. Lombardi, M. Raffaelli, C. De Crea et al., Report on 8 years of experience with video assisted thyroidectomy for papillary thyroid carcinoma. Surgery 142, 944–951 (2007)CrossRefPubMed

33.

N. Chéreau, C. Buffet, C. Trésallet, F. Tissier, L. Leenhardt, F. Menegaux, Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management. Surgery 159(3), 755–762 (2016)CrossRefPubMed

34.

J.Y. Park, B.S. Koo, Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis. Eur. Arch. Otorhinolaryngol. 271(6), 1355–1360 (2014)CrossRefPubMed

35.

F.F. Palazzo, J. Gosnell, R. Savio et al., Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur. J. Surg. Oncol. 32(3), 340–344 (2006)CrossRefPubMed

Titel: Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma
verfasst von: Marco Raffaelli
Carmela De Crea
Luca Sessa
Serena Elisa Tempera
Amanda Belluzzi
Celestino P. Lombardi
Rocco Bellantone
Publikationsdatum: 19.10.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1788-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

ATP mediates a negative autocrine signal on stimulus-secretion coupling in mouse pancreatic β-cells

Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease

Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature

T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists

Critical appraisal and systematic review of guidelines for perioperative diabetes management: 2011–2017

Diagnostic value of ultrasonography and TI-201/Tc-99m dual scintigraphy in differentiating between benign and malignant thyroid nodules

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin